Essais liés2clinical trials
VilleWuhanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06486441

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
SYS6020 injection SEP Phase 1/2 NCT07756268 Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis NOT_YET_RECRUITING
Sacituzumab govitecan-hziy Cancer Phase 3 NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) ACTIVE_NOT_RECRUITING